Anavex Life Sciences Corp.
AVXL
$4.20
-$0.06-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 131.75M | 102.58M | 101.16M | 115.77M | 120.78M |
| Total Receivables | 844.00K | 809.00K | 820.00K | 666.00K | 2.56M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 396.00K | 429.00K | 448.00K | 702.00K | 711.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 132.99M | 103.82M | 102.43M | 117.14M | 124.04M |
|
|
|||||
| Total Current Assets | 132.99M | 103.82M | 102.43M | 117.14M | 124.04M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 132.99M | 103.82M | 102.43M | 117.14M | 124.04M |
|
|
|||||
| Total Accounts Payable | 2.64M | 4.25M | 6.74M | 7.00M | 4.57M |
| Total Accrued Expenses | 2.93M | 3.89M | 3.93M | 9.56M | 7.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 805.00K | 805.00K | 805.00K | 829.00K | 829.00K |
| Total Other Current Liabilities | 805.00K | 805.00K | 805.00K | 829.00K | 829.00K |
| Total Current Liabilities | 6.37M | 8.95M | 11.47M | 17.38M | 13.13M |
|
|
|||||
| Total Current Liabilities | 6.37M | 8.95M | 11.47M | 17.38M | 13.13M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.37M | 8.95M | 11.47M | 17.38M | 13.13M |
|
|
|||||
| Common Stock & APIC | 514.75M | 477.32M | 463.58M | 459.14M | 459.10M |
| Retained Earnings | -388.13M | -382.45M | -372.62M | -359.38M | -348.18M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 126.62M | 94.87M | 90.96M | 99.76M | 110.92M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 126.62M | 94.87M | 90.96M | 99.76M | 110.92M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 126.62M | 94.87M | 90.96M | 99.76M | 110.92M |
|
|
|||||